Agreement on a friendly takeover bid by ONCODNA for INTEGRAGEN at €2.20 per share, for the entire share capital. This transaction would combine OncoDNA's expertise in precision oncology medicine with IntegraGen's know-how in DNA sequencing and bioinformatics analysis services. The combination of the two companies will make it possible to offer a complete solution combining laboratory tests and software in the field of oncology, for the benefit of patients with advanced cancer.
July 09, 2020
Share :
Leave a Reply